Andrew Heron

Overview

CEO and founder of Portal Biotech, biotech entrepreneur with background in Oxford Nanopore next-generation sequencing, now applying molecular biosensing to bioprocessing. Andrew Heron is CEO and founder of Portal Biotech, a London-based company focused on bringing accessible molecular biosensing to biopharma and bioprocessing. Heron spent his career developing next-generation sequencing technologies, specifically Oxford Nanopore sequencing, taking it from academic proof-of-concept through clinical and GMP-regulated sectors. (Segment 1 (00:00-05:00))